Medtronic, a provider of medical technology for use in imaging procedures, has launched a new MR-conditional pacing system in Japan. The new system, Advisa DR MRI SureScan, is designed to provide access to pacemaker patient's to have ...
Tags: Medtronic, medical technology, MR-conditional pacing system
Endosense, a provider of cardiac technologies, has completed enrolling patients in its Toccastar clinical study. The prospective, randomized, multi-center investigational device exemption trial, which enrolled 300 patients with ...
Tags: Endosense, Toccastar clinical study, cardiac technologies
Endosense has obtained CE mark approval for its TactiCath Quartz force-sensing ablation catheter for the treatment of atrial fibrillation and supraventricular tachycardia. The TactiCath Quartz includes a new force sensor that provides ...
Tags: Endosense, TactiCath Quartz
Boston Scientific has entered into a definitive agreement to buy a developer of-gener nextation mapping and navigation systems, Rhythmia Medical. US based Rhythmia Medical's mapping and navigation technologies are used with catheter ...
Tags: mapping and navigation system, acquisition, clinical technology
Boston Scientific, a provider of cardiovascular implants, has completed enrolling patients in its Prevail confirmatory study. The CE-marked self-expanding nitinol frame Watchman device, placed in the left atrial appendage (LAA) via the ...
Tags: Boston Scientific, cardiovascular implants, Prevail confirmatory study
AtriCure, a developer of cardiac surgical ablation systems, has named Michael Carrel as the company's new president and chief executive officer (CEO). Initially, Carrel served at Vital Images, a medical imaging software company, as ...
Tags: management team, new CEO, AtriCure
Boston Scientific has received CE mark approval for an expanded indication of Watchman Left Atrial Appendage (LAA) Closure device, designed to capture any clots that may form in the appendage. The Watchman device also reduces the risk of ...
Tags: CE mark approval, Watchman Device
Janssen Research & Development has submitted a supplemental new drug application (sNDA) with FDA, seeking approval to use Xarelto (rivaroxaban), an oral anticoagulant, to reduce the risk of stent thrombosis in patients with acute coronary ...
The European Commission has cleared an oral anticoagulant, Eliquis, developed by Bristol-Myers Squibb (BMS) and Pfizer. Eliquis 5mg, trade name of apixaban in Europe, is indicated as a twice-daily drug for preventing strokes and systemic ...
Tags: BMS-Pfizer Oral Anticoagulant, oral anticoagulant, Eliquis, apixaban
Bayer oral anticoagulant Xarelto has gained positive common drug review (CDR) recommendation from the Canadian Agency for Drugs and Technologies in Health for the prevention of stroke and systemic embolism in atrial fibrillation (AF) ...
Tags: Bayer oral anticoagulant Xarelto, CDR Recommendation, Stroke Prevention
CardioFocus has reported superior benefits of high-dose laser ablation using its cardiac ablation system when compared to low-dose treatment. Featuring an endoscope for intra-procedural visualization of the beating heart, the HeartLight ...
Tags: laser ablation, superior benefits, high-dose laser ablation
Procedure for treating chronic atrial fibrillation,a condition that causes palpitations and fainting,features a laser balloon catheter. Green light for laser heart treatment? A follow-up study of 56 patients with chronic atrial ...
Tags: Heart Surgery, Laser, EAS